Table 5.
Intervention (n = 10) | Missing | Control (n = 10) | Missing | Mean difference (95% CI) | Effect size | P | |
---|---|---|---|---|---|---|---|
VO2 peak | 2.56 (2.69) | 2 | 2.98 (2.63) | 1 | −0.41 (−3.1, 2.3) | − 0.168 (− 1.4, 1.0) | 0.75 |
6MWT | 42.5 (74.7) | 0 | 26.1 (53.8) | 1 | 16.39 (−47.3, 80.1) | 0.264 (−27.7, 28.2) | 0.59 |
10MWT Self | 0.044 (0.21) | 0 | 0.022 (0.20) | 1 | 0.022 (−0.18, 0.22) | 0.113 (0.0, 0.2) | 0.82 |
10MWT Fast | 0.10 (0.31) | 0 | 0.11 (0.18) | 1 | −0.006 (− 0.26, 0.25) | −0.041 (− 0.2, 0.1) | 0.96 |
SF-36 PCSa | 2.67 (6.41) | 2 | 2.51 (11.18) | 1 | 0.16 (−9.43, 9.75) | 0.018 (−4.1, 4.2) | 0.97 |
SF-36 MCSa | 5.85 (9.31) | 2 | 11.51 (14.86) | 1 | −5.67 (−18.70, 7.36) | −0.479 (− 6.1, 5.1) | 0.37 |
PHQ-9 | −2.8 (7.4) | 0 | −4.3 (3.0) | 1 | 1.53 (−4.0, 7.1) | 0.275 (−2.2, 2.7) | 0.57 |
CI Confidence interval. p values are calculated using independent samples t-tests; except for the 10MWT analyses which were performed using the Mann Whitney U test. VO2 peak = GXT (mL/kg/min); 6MWT Six minute walk test (metres), 10MWT 10 m walk test (m/s), SF-36 Short Form 36, PCS Physical Component Summary Score, MCS Mental Component Summary Score, PHQ-9 Patient Health Questionnaire; total out of 27
One participant in the control group was lost to follow-up [remaining text correct]